Identification of drug-target interaction from interactome network with 'guilt-by-association' principle and topology features

51Citations
Citations of this article
66Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Motivation: Identifying drug-target protein interaction is a crucial step in the process of drug research and development. Wet-lab experiment are laborious, time-consuming and expensive. Hence, there is a strong demand for the development of a novel theoretical method to identify potential interaction between drug and target protein. Results: We use all known proteins and drugs to construct a nodes- and edges-weighted biological relevant interactome network. On the basis of the 'guilt-by-association' principle, novel network topology features are proposed to characterize interaction pairs and random forest algorithm is employed to identify potential drug-protein interaction. Accuracy of 92.53% derived from the 10-fold cross-validation is about 10% higher than that of the existing method. We identify 2272 potential drug-target interactions, some of which are associated with diseases, such as Torg-Winchester syndrome and rhabdomyosarcoma. The proposed method can not only accurately predict the interaction between drug molecule and target protein, but also help disease treatment and drug discovery. Contacts: or ceszxy@mail.sysu.edu.cn Supplementary information: Supplementary data are available at Bioinformatics online.

Cite

CITATION STYLE

APA

Li, Z. C., Huang, M. H., Zhong, W. Q., Liu, Z. Q., Xie, Y., Dai, Z., & Zou, X. Y. (2016). Identification of drug-target interaction from interactome network with “guilt-by-association” principle and topology features. Bioinformatics, 32(7), 1057–1064. https://doi.org/10.1093/bioinformatics/btv695

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free